242 related articles for article (PubMed ID: 30243726)
1. In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.
Kumar PS; Chandrasekhar C; Srikanth L; Sarma PVGK
Biochem Biophys Res Commun; 2018 Oct; 505(1):168-175. PubMed ID: 30243726
[TBL] [Abstract][Full Text] [Related]
2. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
3. Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets.
Wang J; Chen S; Zhang C; Stegeman S; Pfaff-Amesse T; Zhang Y; Zhang W; Amesse L; Chen Y
PLoS One; 2012; 7(8):e44300. PubMed ID: 22952951
[TBL] [Abstract][Full Text] [Related]
4. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
Proulx C; Boyer L; Hurnanen DR; Lemieux R
J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
[TBL] [Abstract][Full Text] [Related]
5. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.
Cramer EM; Norol F; Guichard J; Breton-Gorius J; Vainchenker W; Massé JM; Debili N
Blood; 1997 Apr; 89(7):2336-46. PubMed ID: 9116277
[TBL] [Abstract][Full Text] [Related]
7. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.
Mattia G; Vulcano F; Milazzo L; Barca A; Macioce G; Giampaolo A; Hassan HJ
Blood; 2002 Feb; 99(3):888-97. PubMed ID: 11806991
[TBL] [Abstract][Full Text] [Related]
8. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
[TBL] [Abstract][Full Text] [Related]
9. 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate enhances thrombopoietin-induced megakaryocytic differentiation and plateletogenesis.
Kim J; Jin G; Lee J; Lee K; Bae YS; Kim J
BMB Rep; 2019 Jul; 52(7):434-438. PubMed ID: 30670147
[TBL] [Abstract][Full Text] [Related]
10. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
11. Megakaryocyte and platelet production from human cord blood stem cells.
Robert A; Cortin V; Garnier A; Pineault N
Methods Mol Biol; 2012; 788():219-47. PubMed ID: 22130711
[TBL] [Abstract][Full Text] [Related]
12. [Changes in cyclin expression during proliferation and differentiation of CD34(+) cells derived from fetal liver induced by thrombopoietin].
Ma DC; Jin BQ; Sun YH; Chang KZ; Dai B; Chu JJ; Liu YG
Sheng Li Xue Bao; 2001 Aug; 53(4):296-302. PubMed ID: 11930209
[TBL] [Abstract][Full Text] [Related]
13. Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers.
Yu M; Cantor AB
Methods Mol Biol; 2012; 788():291-303. PubMed ID: 22130715
[TBL] [Abstract][Full Text] [Related]
14. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.
Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM
Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353
[TBL] [Abstract][Full Text] [Related]
15. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Deutsch VR; Tomer A
Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
[TBL] [Abstract][Full Text] [Related]
16. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.
Liu ZJ; Italiano J; Ferrer-Marin F; Gutti R; Bailey M; Poterjoy B; Rimsza L; Sola-Visner M
Blood; 2011 Apr; 117(15):4106-17. PubMed ID: 21304100
[TBL] [Abstract][Full Text] [Related]
17. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
[TBL] [Abstract][Full Text] [Related]
18. Good Manufacturing Practice-Grade of Megakaryocytes Produced by a Novel Ex Vivo Culturing Platform.
Guan X; Wang L; Wang H; Wang H; Dai W; Jiang Y
Clin Transl Sci; 2020 Nov; 13(6):1115-1126. PubMed ID: 33030809
[TBL] [Abstract][Full Text] [Related]
19. Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.
Sim X; Jarocha D; Hayes V; Hanby HA; Marks MS; Camire RM; French DL; Poncz M; Gadue P
Blood; 2017 Jul; 130(2):192-204. PubMed ID: 28455282
[TBL] [Abstract][Full Text] [Related]
20. Targeting expression to megakaryocytes and platelets by lineage-specific lentiviral vectors.
Latorre-Rey LJ; Wintterle S; Dütting S; Kohlscheen S; Abel T; Schenk F; Wingert S; Rieger MA; Nieswandt B; Heinz N; Modlich U
J Thromb Haemost; 2017 Feb; 15(2):341-355. PubMed ID: 27930847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
